These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4724060)
1. [Growth hormone level in the blood serum after fasting in diabetes mellitus in relation to the degree of compensation, the presence of obesity and retinopathy]. Avenirova ZA; Alekeseeva GG; Stepanova NA Probl Endokrinol (Mosk); 1973; 19(3):3-8. PubMed ID: 4724060 [No Abstract] [Full Text] [Related]
2. Abnormal serum growth hormone response to exercise in maturity-onset diabetics. Hansen AP Diabetes; 1973 Aug; 22(8):619-28. PubMed ID: 4724236 [No Abstract] [Full Text] [Related]
3. Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy. Passa P; Gauville C; Canivet J Lancet; 1974 Jul; 2(7872):72-4. PubMed ID: 4136822 [No Abstract] [Full Text] [Related]
4. [Somatotropic hormone in the serum of diabetics]. Dobrev D; Manolov D; Vakov L Vutr Boles; 1981; 20(2):49-53. PubMed ID: 7257332 [TBL] [Abstract][Full Text] [Related]
5. [Content of growth hormone in the blood in insulin-resistant and insulin-sensitive patients with diabetes mellitus during compensation]. Alekseeva GG Probl Endokrinol (Mosk); 1978; 24(1):3-9. PubMed ID: 634944 [TBL] [Abstract][Full Text] [Related]
6. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy. Hanssen KF Acta Endocrinol (Copenh); 1974 Jan; 75(1):64-74. PubMed ID: 4406482 [No Abstract] [Full Text] [Related]
8. [A preliminary study on serum growth hormone concentration in diabetics]. Zhu XX Zhonghua Nei Ke Za Zhi; 1983 Nov; 22(11):691-3. PubMed ID: 6675933 [No Abstract] [Full Text] [Related]
14. Suppression of growth hormone release by glucose administration in diabetic individuals. Bieler EU; Van Rooyen RJ; De Bruin EJ; Hoog JM S Afr Med J; 1973 Jun; 47(25):1117-9. PubMed ID: 4714709 [No Abstract] [Full Text] [Related]
15. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response. Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549 [No Abstract] [Full Text] [Related]
16. [Dynamics of glycemic profile in the combined treatment of diabetes mellitus with insulin and sulfanilamides]. Mordkovskaia NM Probl Endokrinol (Mosk); 1968; 14(3):14-8. PubMed ID: 5734574 [No Abstract] [Full Text] [Related]
17. Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis. Molnar GD; Taylor WF; Langworthy A; Fatourechi V J Clin Endocrinol Metab; 1972 May; 34(5):837-46. PubMed ID: 5012495 [No Abstract] [Full Text] [Related]
18. Plasma levels of growth hormone and glucagon in diabetic patients and relatives of diabetic patients. Knopf RF; Fajans SS; Pek S; Floyd JC; Prchkov VK; Conn JW Adv Metab Disord; 1973; 2():Suppl 2:215-25. PubMed ID: 4720363 [No Abstract] [Full Text] [Related]
19. [Importance of the plasma growth hormone level (HGH) on the development of diabetic retinopathy]. Sévin R Bull Mem Soc Fr Ophtalmol; 1972; 85(0):213-20. PubMed ID: 4671781 [No Abstract] [Full Text] [Related]
20. Metabolic rhythms in normal and diabetic man. Studies in insulin-treated diabetes. Alberti KG; Dornhorst A; Rowe AS Isr J Med Sci; 1975 Jun; 11(6):571-80. PubMed ID: 1158666 [No Abstract] [Full Text] [Related] [Next] [New Search]